Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLivermore Regulatory News (LIV)

Share Price Information for Livermore (LIV)

Share Price is delayed by 15 minutes
Get Live Data
44.60    0.00 (0.00%)
Bid:
42.40
Ask:
47.00
Spread: 4.60 (10.849%)
Market Cap: £73.75m
LIV Live PriceLast checked at - London Stock Exchange

Intraday Livermore Share Chart

AIM Rule 17 – Schedule 2(g) update

27 May 2022 14:36

RNS Number : 1295N
Livermore Investments Group Limited
27 May 2022
 

27 May 2022

LIVERMORE INVESTMENTS GROUP LIMITED

("Livermore" or the "Company")

AIM Rule 17 - Schedule 2(g) update

 

As part of Strand Hanson Limited's ongoing onboarding due diligence, Livermore notifies the following update in relation to directors' disclosure for Noam Lanir, Chief Executive Officer of the Company, pursuant AIM Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

On 22 September 2016, the Administrative Enforcement Committee of the Israel Securities Authority ("the ISA") certified an enforcement arrangement between the ISA and Babylon Limited ("Babylon"), a company listed on the Tel Aviv Stock Exchange, and its officers Alon Carmeli, Noam Lanir, and Shanit Peer Zefoni (the "respondents"). Under the arrangement, Babylon and Carmeli were attributed negligent reporting violations, and negligent inclusion of misstatements in periodic reports was attributed to all respondents. The respondents admitted to the facts stated in the arrangement but did not admit to the commission of the violations. Under the arrangement, a NIS 1 million fine was imposed on Babylon, which undertook to redefine its procedure for issuing immediate reports. A fine of NIS 250,000 was imposed on Alon Carmeli and he was prohibited to serve as a senior officer in a supervised entity for a period of five months. A fine of NIS 150,000 and suspended prohibition to serve as an officer for six months was imposed on Noam Lanir. A fine of NIS 75,000 was imposed on Shanit Peer Zefoni.

Mr Lanir remained Chairman of the Board of Directors of Babylon following the arrangement.

 

For further information please contact: 

Livermore Investments Group Limited

+41 (0) 43 344 3200

Gaurav Suri

 

Strand Hanson Limited (Financial and Nominated Adviser)

+ 44 (0) 20 7409 3494

Richard Johnson, Ritchie Balmer, James Spinney

 

Arden Partners plc (Broker)

+44 (0) 20 7614 5900

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFVVEEIDFIF
Date   Source Headline
27th May 20267:00 amRNSFinal Results
18th Feb 20267:45 amRNSAppointment of Directors
13th Nov 20251:00 pmRNSMajor shareholding notification
22nd Oct 20257:00 amRNSAppointment of Non-Executive Director
26th Sep 20257:00 amRNSInterim Results
26th Aug 20256:00 pmRNSResults of AGM and Board Change
1st Jul 20257:00 amRNSPosting of Accounts and Notice of AGM
23rd Jun 20254:01 pmRNSInterim Dividend Exchange Rate
23rd May 20253:09 pmRNSInterim Dividend
23rd May 20257:00 amRNSFinal Results
2nd Jan 20257:00 amRNSDirectorate Change
8th Nov 20247:00 amRNSInterim dividend exchange rate
30th Sep 20247:00 amRNSInterim Dividend
26th Sep 20247:00 amRNSInterim Results
27th Aug 20242:05 pmRNSResult of AGM
28th Jun 202411:00 amRNSPosting of Accounts and Notice of AGM
23rd May 20247:00 amRNSFinal Results
18th Dec 20234:23 pmRNSInterim dividend exchange rate
6th Dec 20234:10 pmRNSFurther re Interim Dividend
21st Nov 20237:00 amRNSInterim Dividend
29th Sep 20237:00 amRNSInterim Results
29th Aug 202311:30 amRNSResult of AGM
3rd Aug 20237:55 amRNSCorrection of AGM date
29th Jun 202311:00 amRNSPosting of Report and Accounts and Notice of AGM
22nd May 20237:05 amRNSDirector transfer of shares
22nd May 20237:00 amRNSFinal Results
24th Jan 20231:07 pmRNSChange of Adviser
30th Sep 20227:00 amRNSInterim Results
23rd Aug 202212:01 pmRNSResult of Annual General Meeting
18th Jul 202210:58 amRNSCompletion of Nominated Adviser Due Diligence
30th Jun 202210:14 amRNSPosting of Report and Accounts and Notice of AGM
30th May 20227:00 amRNSFinal Results
27th May 20222:36 pmRNSAIM Rule 17 – Schedule 2(g) update
27th Apr 202211:00 amRNSAppointment of Nominated Adviser
26th Apr 202210:27 amRNSAIM Rule 17 - historic disclosure
5th Jan 20227:00 amRNSDividend Declaration
12th Oct 20217:00 amRNSDirector/PDMR Shareholding
29th Sep 20214:30 pmRNSInterim Results
25th Aug 20212:02 pmRNSResult of Annual General Meeting
30th Jun 20217:00 amRNSAnnual Report and Notice of AGM
26th May 20217:00 amRNSFinal Results
10th May 20214:41 pmRNSSecond Price Monitoring Extn
10th May 20214:35 pmRNSPrice Monitoring Extension
8th Mar 20212:52 pmRNSInterim Dividend Declaration
18th Feb 20219:00 amRNSDirector dealing, Share buyback and TVR
28th Sep 20209:30 amRNSINTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2020
25th Aug 202011:37 amRNSResult of AGM
19th Aug 20207:00 amRNSAGM - change of location
8th Jul 20207:00 amRNSAGM - revised Forms of Proxy and Direction
26th Jun 202011:36 amRNSPosting of Report and Accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.